About Strados

News

The latest press releases, research announcements, and conference presentations from Strados Labs.

Strados Labs Completes Acquisition of NuvoAir's Clinical Trial Business, Creating the First Full-Spectrum Respiratory Endpoint Intelligence Company.
Press ReleaseApril 2026

Strados Labs Completes Acquisition of NuvoAir's Clinical Trial Business, Creating the First Full-Spectrum Respiratory Endpoint Intelligence Company.

Strados Labs today announced the completion of its acquisition of NuvoAir's clinical trial business, uniting validated remote spirometry, FeNO, and eCOA with Strados's gold-standard cough monitoring and lung sound analysis. [PLACEHOLDER: Gabe to insert executive quotes from Strados and NuvoAir leadership before launch. Include quote from CEO Nick Delmonico and at least one external voice — sponsor, KOL, or CRO partner.]

Link to be added before launch
Strados Labs Announces Study Evaluating Remote Lung Sound Monitoring to Predict COPD Exacerbations
Press ReleaseJan 28, 2026

Strados Labs Announces Study Evaluating Remote Lung Sound Monitoring to Predict COPD Exacerbations

The SHORE study, in collaboration with Jefferson Health, will assess the feasibility of home-based, continuous monitoring of cough and lung sounds including wheeze and rhonchi following COPD exacerbations.

Read more
Strados Labs Collaborates with Rutgers Robert Wood Johnson Medical School, RWJBarnabas Health to Evaluate Wearable Respiratory Monitoring in Cystic Fibrosis
Press ReleaseAug 28, 2025

Strados Labs Collaborates with Rutgers Robert Wood Johnson Medical School, RWJBarnabas Health to Evaluate Wearable Respiratory Monitoring in Cystic Fibrosis

The pilot study explores the RESP® Biosensor's potential to allow for low-effort home monitoring in patients with acute and chronic cystic fibrosis.

Read more
Strados Labs Accelerates Research into Continuous Lung Sound Monitoring in 2025
NewsAug 25, 2025

Strados Labs Accelerates Research into Continuous Lung Sound Monitoring in 2025

Strados Labs, a medical technology company focused on improving surveillance of respiratory diseases, is proud to announce a series of ongoing research collaborations in 2025 with leading academic institutions.

Read more
Join Strados Labs' Session at ATS 2025 on Cough in Pulmonary Fibrosis, led by Dr. Toby Maher
EventMay 1, 2025

Join Strados Labs' Session at ATS 2025 on Cough in Pulmonary Fibrosis, led by Dr. Toby Maher

Please join Strados Labs at ATS 2025 for an engaging session on the often-overlooked symptom of cough in pulmonary fibrosis, led by Dr. Toby Maher, Professor of Clinical Medicine at Keck School of Medicine, USC.

Read more
Strados Labs to Present Developments in Cough Monitoring at ATS 2025
EventApr 22, 2025

Strados Labs to Present Developments in Cough Monitoring at ATS 2025

Strados Labs looks forward to participating in the American Thoracic Society (ATS) 2025 International Conference from May 16–21 in San Francisco, CA.

Read more
Strados Labs Introduces Grant Initiative to Accelerate Research into Continuous Lung Sound Monitoring
Press ReleaseMar 25, 2025

Strados Labs Introduces Grant Initiative to Accelerate Research into Continuous Lung Sound Monitoring

The new program provides eligible research studies with in-kind support for the use of the RESP® Biosensor system.

Read more

Ready to design your respiratory study?

Tell us about your program and we'll help you design the right respiratory endpoint strategy.

Design a Study
base44
Edit with Base44